Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07102030Recruiting

Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment

Role: collaborator

NCT00643006Not ApplicableCompleted

Physical Exercise and Its Impact on Signs of Inflammation in Fibromyalgia

Role: collaborator

NCT01004458Not ApplicableCompleted

Cognitive Behavioral Therapy Trial in Fibromyalgia

Role: collaborator

All 3 trials loaded